Bristol-Myers Squibb
BMY
BMY
2,186 hedge funds and large institutions have $98.7B invested in Bristol-Myers Squibb in 2020 Q2 according to their latest regulatory filings, with 158 funds opening new positions, 939 increasing their positions, 819 reducing their positions, and 99 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
9% less call options, than puts
Call options by funds: $1.44B | Put options by funds: $1.58B
1.38% less ownership
Funds ownership: 75.85% → 74.47% (-1.4%)
19% less funds holding in top 10
Funds holding in top 10: 135 → 110 (-25)
Holders
2,186
Holding in Top 10
110
Calls
$1.44B
Puts
$1.58B
Top Buyers
| 1 | +$578M | |
| 2 | +$322M | |
| 3 | +$298M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$281M |
| 5 |
JP Morgan Chase
New York
|
+$246M |
Top Sellers
| 1 | -$1.35B | |
| 2 | -$709M | |
| 3 | -$506M | |
| 4 |
Dodge & Cox
San Francisco,
California
|
-$462M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$435M |